Kyverna Therapeutics, Inc. (KYTX)
8.24
-0.18
(-2.14%)
USD |
NASDAQ |
Aug 24, 16:00
8.39
+0.15
(+1.82%)
Pre-Market: 07:59
Kyverna Therapeutics Total Return Level : 8.24 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 8.24 |
| August 21, 2026 | 8.42 |
| August 20, 2026 | 8.13 |
| August 19, 2026 | 8.87 |
| August 18, 2026 | 8.50 |
| August 17, 2026 | 8.95 |
| August 14, 2026 | 8.17 |
| August 13, 2026 | 8.08 |
| August 12, 2026 | 8.05 |
| August 11, 2026 | 8.02 |
| August 10, 2026 | 7.89 |
| August 07, 2026 | 7.96 |
| August 06, 2026 | 7.75 |
| August 05, 2026 | 7.64 |
| August 04, 2026 | 7.78 |
| August 03, 2026 | 7.51 |
| July 31, 2026 | 7.30 |
| July 30, 2026 | 7.49 |
| July 29, 2026 | 7.07 |
| July 28, 2026 | 7.49 |
| July 27, 2026 | 7.92 |
| July 24, 2026 | 7.41 |
| July 23, 2026 | 7.29 |
| July 22, 2026 | 7.40 |
| July 21, 2026 | 7.48 |
| Date | Value |
|---|---|
| July 20, 2026 | 7.24 |
| July 17, 2026 | 7.45 |
| July 16, 2026 | 7.44 |
| July 15, 2026 | 7.78 |
| July 14, 2026 | 7.94 |
| July 13, 2026 | 7.77 |
| July 10, 2026 | 8.485 |
| July 09, 2026 | 9.81 |
| July 08, 2026 | 9.91 |
| July 07, 2026 | 9.68 |
| July 06, 2026 | 9.16 |
| July 02, 2026 | 8.89 |
| July 01, 2026 | 8.44 |
| June 30, 2026 | 8.91 |
| June 29, 2026 | 8.78 |
| June 26, 2026 | 8.44 |
| June 25, 2026 | 8.20 |
| June 24, 2026 | 8.62 |
| June 23, 2026 | 8.43 |
| June 22, 2026 | 8.30 |
| June 18, 2026 | 8.07 |
| June 17, 2026 | 8.04 |
| June 16, 2026 | 7.92 |
| June 15, 2026 | 8.15 |
| June 12, 2026 | 8.055 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Cartesian Therapeutics, Inc. | 10.06 |
| Allogene Therapeutics, Inc. | 2.03 |
| Beam Therapeutics, Inc. | 28.33 |
| Arrowhead Pharmaceuticals, Inc. | 86.73 |
| Oncolytics Biotech, Inc. | 0.8441 |